MedPath

Continuous Spinal Anesthesia in Renal Transplantation

Not Applicable
Active, not recruiting
Conditions
Anesthesia
Transplant;Failure,Kidney
Renal Failure Chronic
Registration Number
NCT03436368
Lead Sponsor
Nazmy Edward Seif
Brief Summary

Renal transplantation is now recognized as a treatment of choice for patients with end-stage renal disease. An adequate anesthetic technique should achieve hemodynamic stability and enhance perfusion of the transplanted kidney. The aim of this study is to assess the use \& effects of continuous spinal anesthesia for kidney transplantation recipients, compared with balanced general anesthesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA class III or IV
  • End-stage renal disease
  • Renal transplantation candidate patients
Exclusion Criteria
  • Any condition contra-indicating regional anesthesia
  • Coagulopathy
  • Allergic to any of the drugs used during the procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Mean ABP12 hours

Change in Mean Arterial Blood Pressure measured in mmHg.

Secondary Outcome Measures
NameTimeMethod
Patient satisfaction score24 hours

Patient satisfaction Score defines the degree of patient satisfaction with the anesthetic experience and is assessed after recovery. It is graded as excellent "E" (best score), fair "F" or poor "P" (worst score).

Visual Analogue Score for pain "VAS"12 hours

Visual Analogue Score for pain measures the degree of pain experienced by the patient during the procedure. VAS is graded from 0-10 \[where 0=no pain, 10= worst pain\].

Trial Locations

Locations (1)

Kasr Al-Ainy Hospital, Cairo University

🇪🇬

Cairo, Egypt

Kasr Al-Ainy Hospital, Cairo University
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.